文献速递妇产影像腹部MR

磁共振成像评估胎儿肝脂质含量及其与母体及胎儿临床参数的关系

Assessment of fetal hepatic lipid content by magnetic resonance imaging and association of results with clinical maternal and fetal parameters.
PubMed 文献 · Eur J Radiol · 2025-03-19

该前瞻性研究对155例胎儿在临床常规全身MRI中行多回波CSE-MRI序列,量化肝质子密度脂肪分数。151/155(97.4%)例成功,脂肪分数范围0%–5.7%(均值2.26,SD 1.37)。肝细胞脂质与母体糖尿病存在相关(p=0.027),与母体BMI、年龄、孕周、估计胎儿体重、胎儿性别及出生体重无关联。

要点

  • 胎儿肝质子密度脂肪分数可行,成功率达97.4%。
  • 肝细胞脂质与母体糖尿病相关(p=0.027)。
  • 与母体BMI、年龄、孕周、胎儿体重、性别及出生体重无关联。

核心结论

  • 胎儿肝细胞脂质量化可行,可在全身MRI中常规进行,以检测早期肝脏脂肪堆积,尤其在母体糖尿病存在时。

研究设计与样本

  • 前瞻性研究,155例胎儿,孕19–38周,1.5特斯拉扫描仪,多回波CSE-MRI序列,测量肝左、右叶质子密度脂肪分数,右叶结果与母体及胎儿参数相关分析。

关键影像表现/征象

  • 胎儿肝质子密度脂肪分数范围0%–5.7%,均值2.26,SD 1.37。
  • 4例检查因严重运动伪影和图像质量差被排除。

诊断标准与关键数值

  • 量化成功151/155(97.4%),排除标准为严重运动伪影和图像质量差。

临床应用与阅片要点

  • 胎儿肝脂质定量可在临床常规全身MRI中完成,尤其关注母体糖尿病孕妇。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To quantify hepatocellular lipids in the fetal liver, we tested the feasibility of the multiecho mDixon Quant sequence (chemical shift encoded magnetic resonance imaging (MRI)) during clinically routine fetal whole-body MRI and investigated the correlation of hepatocellular lipids with different clinical maternal and fetal parameters.

METHODS: The livers of 155 fetuses were prospectively investigated with multiecho CSE-MRI sequences during clinically indicated whole-body MRI, performed between gestational weeks 19 and 38 on a 1.5 Tesla scanner. The hepatocellular lipids were quantified by measuring the proton density fat fraction in the left and right liver lobe. Results of the right liver lobe were correlated with the maternal body mass index, maternal age, presence of maternal diabetes, gestational age at assessment, estimated fetal weight, fetal sex, and birth weight.

RESULTS: Quantification of fetal hepatocellular lipids was feasible in 151/155 (97.4 %) fetuses. Four examinations were excluded due to strong motion artifacts and poor image quality. The proton density fat fraction values ranged from 0 % to 5.7 % (mean 2.26; SD 1.37). Hepatocellular lipids were associated with the presence of maternal diabetes (p = 0.027). No association was found between hepatocellular lipids and maternal body mass index (p = 0.306), maternal age (p = 0.582), gestational age (p = 0.456), estimated fetal weight (p = 0.176), fetal sex (p = 0.181), or birth weight (p = 0.957).

CONCLUSION: Quantification of fetal hepatocellular lipids is feasible and may routinely be performed during whole-body MRI to detect early liver fat accumulation, particularly in the presence of maternal diabetes.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Berger-Kulemann V, Prayer D, Sieberer N, et al. Assessment of fetal hepatic lipid content by magnetic resonance imaging and association of results with clinical maternal and fetal parameters. Eur J Radiol. 2025. PMID: 40138805. doi:10.1016/j.ejrad.2025.112061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。